α1-adrenoceptor antagonists.: 6.: structural optimization of pyridazinone-arylpiperazines.: Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety

被引:34
作者
Betti, L
Corelli, F
Floridi, M
Giannaccini, G
Maccari, L
Manetti, F
Strappaghetti, G
Botta, M
机构
[1] Univ Perugia, Ist Chim & Tecnol Farmaco, I-06123 Perugia, Italy
[2] Univ Siena, Dipartimento Farmacochim Tecnol, I-53100 Siena, Italy
[3] Univ Pisa, Dipartimento Psichiat Neurobiol Farmacol & Biotec, I-56126 Pisa, Italy
关键词
D O I
10.1021/jm0307842
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In continuing our search for selective alpha(1)-adrenoceptor (AR) antagonists, we have synthesized new alkoxyarylpiperazinylalkylpyridazinone derivatives. The new compounds were tested for their affinity toward alpha(1)- and alpha(2)-AR and toward the 5-HT1A receptor. alpha(1)-AR affinity data are in the subnanomolar range, with 3 showing an affinity of 0.052 nM, about 5-fold higher than prazosin. None of the studied compounds was found to be alpha(1)/alpha(2) selective, but 8 showed an interesting 5-HT1A/alpha(1) affinity ratio of 119.
引用
收藏
页码:3555 / 3558
页数:4
相关论文
共 5 条
[1]   Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward α1- and α2-adrenoceptors [J].
Barbaro, R ;
Betti, L ;
Botta, M ;
Corelli, F ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) :2118-2132
[2]   α1-adrenoceptor antagonists.: 4.: Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives [J].
Betti, L ;
Botta, M ;
Corelli, F ;
Floridi, M ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Tafi, A ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3603-3611
[3]   α1-adrenoceptor antagonists.: 5.: Pyridazinone-arylpiperazines.: Probing the influence on affinity and selectivity of both ortho-alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus [J].
Betti, L ;
Floridi, M ;
Giannaccini, G ;
Manetti, F ;
Strappaghetti, G ;
Tafi, A ;
Botta, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) :171-173
[4]  
BETTI L, 2002, Patent No. 000362
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099